Temporal stability of the Unified Dyskinesia Rating Scale

Mov Disord. 2011 Dec;26(14):2556-9. doi: 10.1002/mds.23931. Epub 2011 Sep 13.

Abstract

Background: The objective of this study was to establish temporal stability characteristics for objective components of the Unified Dyskinesia Rating Scale (UDysRS). The UDysRS has strong internal consistency and a reliable factor structure, but the important issue of temporal stability has not been established.

Methods: Using intraclass correlation coefficient (ICC) analyses, we examined UDysRS temporal stability for the objective scale components (Part III and IV) over an 8-hour observation period. We assessed ICCs for the single centralized rater, the on-site raters, and the agreement between the single centralized rater and the on-site raters. Kappa statistic assessed agreement between the single centralized and on-site raters for clinical state (ON vs OFF).

Results: For both the single centralized rater and the on-site raters, there was high temporal stability of the UDysRS Part III, Part IV, and Total Objective UDysRS in both ON and OFF states, with ICCs ranging from 0.822 (P < .0005) to 0.513 (P < .013). The agreement between the 2 rating techniques (centralized vs on-site) was significant for ON and OFF ratings of Part III, Part IV, and Total Objective UDysRS, ranging from 0.821 (P < .0005) to 0.703 (P < .0005).

Conclusions: The UDysRS is highly stable for ON and OFF. Our data suggest that a single UDysRS evaluation for ON and for OFF states is highly representative of that state regardless of time. Likewise, if appropriate protocols need to assess dyskinesia in a field or community setting, the UDysRS can be filmed without an on-site rater and rated centrally with retained validity.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Aged
  • Benzothiazoles / administration & dosage
  • Benzothiazoles / adverse effects
  • Benzoxazoles / administration & dosage
  • Benzoxazoles / adverse effects
  • Disability Evaluation*
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / adverse effects*
  • Dyskinesia, Drug-Induced / diagnosis*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination / methods
  • Neurologic Examination / standards*
  • Neurologic Examination / statistics & numerical data
  • Observer Variation
  • Parkinson Disease / drug therapy*
  • Piperazines / administration & dosage
  • Piperazines / adverse effects
  • Pramipexole
  • Reproducibility of Results
  • Videotape Recording

Substances

  • Benzothiazoles
  • Benzoxazoles
  • Dopamine Agonists
  • Piperazines
  • pardoprunox
  • Pramipexole